INTERACTION OF THE ALPHA-ADRENOCEPTOR AGONIST OXYMETAZOLINE WITH SEROTONIN 5-HT1A-RECEPTORS, 5-HT1B-RECEPTORS, 5-HT1C-RECEPTORS AND 5-HT1D-RECEPTORS

被引:38
作者
SCHOEFFTER, P
HOYER, D
机构
[1] Preclinical Research, Sandoz Pharma Ltd., CH-4002 Basel
关键词
OXYMETAZOLINE; 5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); 5-HT1A-RECEPTORS; 5-HT1B-RECEPTORS; 5-HT1C-RECEPTORS; 5-HT1D-RECEPTORS;
D O I
10.1016/0014-2999(91)90432-P
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxymetazoline was recognized with nanomolar affinity by 5-HT1A, 5-HT1B and 5-HT1D binding sites and mimicked the effects of 5-hydroxytryptamine with about the same potency and intrinsic activity as the endogenous amine in the corresponding functional tests. At 5-HT1C receptors, oxymetazoline behaved as a mixed agonist-antagonist. Clonidine had minimal activity. Methiothepin antagonized the effects of oxymetazoline (7.4 < pK(B) < 8.8). Thus, oxymetazoline is a full and potent agonist at 5-HT1A, 5-HT1B and 5-HT1D receptors and a partial agonist at 5-HT1C receptors.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 10 条
[1]  
FUDER H, 1986, J PHARMACOL EXP THER, V237, P237
[2]   THE DETERMINATION OF PRE-SYNAPTIC PA2 VALUES OF YOHIMBINE AND PHENTOLAMINE ON THE PERFUSED RAT-HEART UNDER CONDITIONS OF NEGLIGIBLE AUTOINHIBITION [J].
FUDER, H ;
MUSCHOLL, E ;
SPEMANN, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 79 (01) :109-119
[3]  
HOYER D, 1989, N-S ARCH PHARMACOL, V339, P252
[4]  
MULLERSCHWEINIT.E, 1986, NEURAL REGULATION BR, P219
[5]  
MURPHY TJ, 1988, MOL PHARMACOL, V34, P1
[6]   5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES - MOLECULAR, BIOCHEMICAL AND PHYSIOLOGICAL CHARACTERIZATION [J].
PEROUTKA, SJ .
TRENDS IN NEUROSCIENCES, 1988, 11 (11) :496-500
[7]  
SCHOEFFTER P, 1988, N-S ARCH PHARMACOL, V337, P602
[8]  
SCHOEFFTER P, 1989, N-S ARCH PHARMACOL, V339, P675
[9]   CENTRALLY ACTING HYPOTENSIVE AGENTS WITH AFFINITY FOR 5-HT1A BINDING-SITES INHIBIT FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY IN CALF HIPPOCAMPUS [J].
SCHOEFFTER, P ;
HOYER, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :975-985
[10]  
WAEBER C, 1988, N-S ARCH PHARMACOL, V337, P595